Predicted Trait | |
Reported Trait | Breast cancer |
Mapped Trait(s) | breast carcinoma (EFO_0000305) |
Score Construction | |
PGS Name | ldpred2.CV.GCST004988.Breast_cancer |
Development Method | |
Name | LDpred2.CV |
Parameters | p:0.01,h2:0.1164,nosparse |
Variants | |
Original Genome Build | GRCh38 |
Number of Variants | 1,041,298 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000517 |
Citation (link to publication) | Monti R et al. Am J Hum Genet (2024) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004988 Europe PMC: 29059683 |
139,274 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | 12,483 individuals, 0.0 % Male samples |
European | UKB | — | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM019365 | PSS011215| European Ancestry| 130,758 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Breast cancer | β: 0.50696 [0.46857737, 0.54535222] OR: 1.66024 [1.59771962, 1.72521592] |
AUROC: 0.64155 [0.63100072, 0.65209011] | R²: 0.05592 [0.04878852, 0.06462078] | 0 | beta = log(or)/sd_pgs |
PPM019366 | PSS011227| European Ancestry| 217,530 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Breast cancer | OR: 1.77072 [1.74154078, 1.80038299] β: 0.57138 [0.55477023, 0.58799941] |
AUROC: 0.65624 [0.65188392, 0.66059213] | R²: 0.06923 [0.06509505, 0.07276728] | 0 | beta = log(or)/sd_pgs |
PPM019367 | PSS011238| South Asian Ancestry| 24,319 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Breast cancer | OR: 1.60503 [1.39429381, 1.84761448] β: 0.47314 [0.33238806, 0.61389534] |
AUROC: 0.62871 [0.58989471, 0.66752285] | R²: 0.0394 [0.01850853, 0.06709891] | 0 | beta = log(or)/sd_pgs |
PPM019368 | PSS011254| European Ancestry| 35,377 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Breast cancer | OR: 1.74575 [1.66147743, 1.8343018] β: 0.55719 [0.50770723, 0.60666392] |
AUROC: 0.64976 [0.63666034, 0.66286316] | R²: 0.06621 [0.05482, 0.07762809] | 0 | beta = log(or)/sd_pgs |
PPM019369 | PSS011282| South Asian Ancestry| 4,350 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Breast cancer | OR: 1.46589 [1.26693944, 1.69608562] β: 0.38246 [0.2366041, 0.52832302] |
AUROC: 0.60655 [0.56457528, 0.64853134] | R²: 0.02531 [0.00997384, 0.04844316] | 0 | beta = log(or)/sd_pgs |
PPM019370 | PSS011268| European Ancestry| 48,968 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Breast cancer | OR: 1.80882 [1.74205374, 1.87814873] β: 0.59268 [0.55506473, 0.63028658] |
AUROC: 0.65979 [0.65003927, 0.66954015] | R²: 0.07392 [0.06512011, 0.08357077] | 0 | beta = log(or)/sd_pgs |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011215 | — | — | [ ,
0.0 % Male samples |
— | European | — | EB | — |
PSS011282 | — | — | [ ,
0.0 % Male samples |
— | South Asian | — | UKB | — |
PSS011254 | — | — | [ ,
0.0 % Male samples |
— | European | — | HUNT | — |
PSS011227 | C3_BREAST, ICD10: C0, ICD9: 174 | — | [ ,
0.0 % Male samples |
— | European | — | FinnGen | — |
PSS011268 | — | — | [ ,
0.0 % Male samples |
— | European | — | UKB | — |
PSS011238 | — | — | [ ,
0.0 % Male samples |
— | South Asian | — | G&H | — |